|Mr. Andrew A. DeFrancesco||Chairman & CEO||674.24k||N/A||1970|
|Mr. Peter D. Liabotis CPA, CA||Special Advisor||177.41k||N/A||1970|
|Mr. Paul L. Kania CPA, CPA||Chief Financial Officer||N/A||N/A||N/A|
|Prof. Michael Barnes M.D.||Chief Medical Officer||N/A||N/A||N/A|
|Mr. Micheal Bondurant||Chief Strategy Officer||N/A||N/A||1970|
|Mr. Paul T. Norman||Chief Exec. Officer of HeavenlyRx||N/A||N/A||1965|
SOL Global Investments Corp. is a principal investment firm with a focus on the biopharmaceutical and cannabis industry in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018. SOL Global Investments Corp. is based in Toronto, Canada.
SOL Global Investments Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.